
U.S. House Updates @HouseFloor
8:23:21 p.m. - #HR7667 - Considered as unfinished business. #HR7667 - "To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products" https://t.co/odbWABa1ZN — PolitiTweet.org